About
Technology
Issues
FAQ
Links
Official Page
Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta‐analysis and systemic review
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.